Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Mini Review Volume 6 Issue 5

Medicare’s 30-days Readmission Rule in the United States: A Review and Recommendations

Iqbal Ratnani1*, Annum Faisal2, Parisa Aijaz3, Samia Nadeem4 and Salim Surani5

1DeBakey Heart and Vascular Center, Houston, Texas, USA
2Texas College of Osteopathic Medicine, Fort Worth, Texas, USA
3Dow University of Health Sciences, Karachi, Pakistan
4Shifa College of Medicine, Islamabad, Pakistan
5Texas A&M University, College Station, Texas, USA

*Corresponding Author: Iqbal Ratnani, DeBakey Heart and Vascular Center, Houston, Texas, USA.

Received: February 28, 2022; Published: April 22, 2022

Abstract

This review intends to explain the Center for Medicare and Medicaid Services (CMS) 30-days unplanned readmission rule under its Hospital Reduction Readmission Program (HRRP). In this article, we will briefly define this rule with its intent, origin, impact on patients, hospitals, and staff/managers. In other words, we will describe who, what, when, where, why, and how this rule applies. We would also make some recommendations in this regard.

Keywords: Medicare; Readmissions; 30-days rule; CMS; Hospital Reduction Readmission Program

References

  1. Flaks-Manov Natalie., et al. “Identifying Patients at Highest-Risk: The Best Timing to Apply a Readmission Predictive Model”. BMC Medical Informatics and Decision Making1 (2019).
  2. Flaks-Manov Natalie., et al. “Preventing Hospital Readmissions: Healthcare Providers’ Perspectives on ‘Impactibility’ beyond Ehr 30-Day Readmission Risk Prediction”. Journal of General Internal Medicine5 (2020): 1484–1489.
  3. Gupta Ankur and Gregg C Fonarow. “The Hospital Readmissions Reduction Program-Learning from Failure of a Healthcare Policy”. European Journal of Heart Failure8 (2018): 1169-1174.
  4. “Hospital Readmission Reduction”. CMS, Centers for Medicare and Medicaid Services.
  5. “Hospital Readmissions Reduction Program (HRRP)”. CMS, Centers for Medicare and Medicaid Services.
  6. Jencks Stephen F., et al. “Rehospitalizations among Patients in the Medicare Fee-for-Service Program”. New England Journal of Medicine14 (2009): 1418-1428.
  7. Kripalani Sunil., et al. “Reducing Hospital Readmission Rates: Current Strategies and Future Directions”. Annual Review of Medicine1 (2014): 471-485.
  8. Leppin Aaron L., et al. “Preventing 30-Day Hospital Readmissions”. JAMA Internal Medicine7 (2014): 1095.
  9. McIlvennan, Colleen K.., et al. “Hospital Readmissions Reduction Program”. Circulation20 (2015): 1796-1803.
  10. Medicare Payment Advisory Commission (U.S.) Report to the Congress: Promoting Greater Efficiency in Medicare (2007).
  11. Medicare Payment Advisory Commission (U.S.) Report to the Congress: Reforming the Delivery System (2007).
  12. “Hospitals Are Avoiding Admitting Medicare Patients to Dodge Financial Penalties, Study Suggests”. Advisory Board, Advisory Board, 5 Sept. (2019).
  13. “Readmission Reduction Incentive Program (RRIP)”. The Maryland Health Services Cost Review Commission.
  14. Rennke Stephanie., et al. “Hospital-Initiated Transitional Care Interventions as a Patient Safety Strategy”. Annals of Internal Medicine5 (2013): 433.
  15. Wadhera Rishi K., et al. “Hospital Revisits within 30 Days after Discharge for Medical Conditions Targeted by the Hospital Readmissions Reduction Program in the United States: National Retrospective Analysis”. BMJ (2019): l4563.

Citation

Citation: Iqbal Ratnani., et al. “Medicare’s 30-days Readmission Rule in the United States: A Review and Recommendations”.Acta Scientific Medical Sciences 6.5 (2022): 165-167.

Copyright

Copyright: © 2022 Iqbal Ratnani., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


Contact US